NEU neuren pharmaceuticals limited

“These autism/neurodevelopmental disorder patents make claim for...

  1. 2,113 Posts.
    lightbulb Created with Sketch. 551
    “These autism/neurodevelopmental disorder patents make claim for NNZ-2591 producing an improvement in one or more of a wide range of symptoms, including many of those being assessed in the current Phase 2 trials.”
    Truly great post; I’ll guarantee that 90% of holders here or the stock in general didn’t realize the above, thanks again Hottod for all your research.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.28
Change
0.080(0.56%)
Mkt cap ! $1.777B
Open High Low Value Volume
$14.22 $14.55 $14.10 $4.611M 320.2K

Buyers (Bids)

No. Vol. Price($)
1 6352 $14.28
 

Sellers (Offers)

Price($) Vol. No.
$14.38 4000 1
View Market Depth
Last trade - 16.10pm 04/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.